Publications by authors named "Scott J Antonia"

83Publications

Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells.

Cell Metab 2020 Sep 7;32(3):420-436.e12. Epub 2020 Aug 7.

Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA; Department of Radiation Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmet.2020.07.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484212PMC
September 2020

The immunotherapeutic landscape in non-small cell lung cancer and its surgical horizons.

J Thorac Cardiovasc Surg 2020 04 10;159(4):1616-1623. Epub 2019 Dec 10.

Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC; Duke Cancer Institute, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2019.08.138DOI Listing
April 2020

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. Reply.

Authors:
Scott J Antonia

N Engl J Med 2019 03;380(10):990

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMc1900407
Publisher Site
http://dx.doi.org/10.1056/NEJMc1900407DOI Listing
March 2019

The NKG2A immune checkpoint - a new direction in cancer immunotherapy.

Nat Rev Clin Oncol 2019 05;16(5):277-278

Thoracic Oncology Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-019-0182-8DOI Listing
May 2019

Clinical associations of mucin 1 in human lung cancer and precancerous lesions.

Oncotarget 2018 Nov 2;9(86):35666-35675. Epub 2018 Nov 2.

Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26278DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235019PMC
November 2018

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.

N Engl J Med 2018 12 25;379(24):2342-2350. Epub 2018 Sep 25.

From the H. Lee Moffitt Cancer Center and Research Institute, Tampa (S.J.A., A.C., J.E.G.), Cancer Specialists of North Florida, Jacksonville (A.V.), Florida Cancer Specialists, Fleming Island (A.V.), and Florida Hospital Cancer Institute, Orlando (T.M.) - all in Florida; Tennessee Oncology, Chattanooga (D.D.), and Sarah Cannon Research Institute, Nashville (D.D., D.R.S.) - both in Tennessee; Hospital Universitario Virgen Macarena, Seville (D.V.), and Hospital Universitario 12 de Octubre, CiberOnc, Universidad Complutense and Spanish National Cancer Research Center (L.P.-A.), and Hospital Universitario La Paz (J.C.C.), Madrid - all in Spain; Kanagawa Cancer Center, Yokohama (S.M.), Kansai Medical University Hospital, Hirakata (T.K.), Kurume University Hospital, Kurume (T.T.), and Nippon Medical School Hospital, Tokyo (K.K.) - all in Japan; Westmead Hospital and the University of Sydney, Sydney (R.H.), and Flinders University and Flinders Medical Centre, Adelaide, SA (C.S.K.) - all in Australia; Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju (K.H.L.), Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju (Y.-C.K.) - all in South Korea; Vivantes Klinikum Neukoelln, Berlin (M.W.), and the Lung Clinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf (M.R.) - both in Germany; Centre Hospitalier Universitaire de Liège, Liège (M.B.), and University Hospitals KU Leuven, Leuven (J.V.) - both in Belgium; Centre Hospitalier Universitaire de Montpellier and Institut du Cancer de Montpellier Val d'Aurelle, Montpellier (X.Q.), Institut Gustave Roussy, Villejuif (D.P.), and Institut de Cancérologie de l'Ouest-site René Gauducheau, Saint Herblain (S.H.) - all in France; National Koranyi Institute of Pulmonology, Budapest, Hungary (G.O.); the University of Manchester and the Christie NHS Foundation Trust, Manchester (C.F.-F.), AstraZeneca, Alderley Park (C.W.), and AstraZeneca, Cambridge (M.T.) - all in the United Kingdom; AstraZeneca, Gaithersburg, MD (G.M., P.A.D.); and Istanbul University-Cerrahpasa, Cerrahpasa School of Medicine, Istanbul, Turkey (M.Ö.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1809697DOI Listing
December 2018

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.

Cancer Cell 2018 05 12;33(5):843-852.e4. Epub 2018 Apr 12.

Department of Medicine, Memorial Sloan Kettering Cancer Center, 885 2(nd) Avenue, New York, NY 10017, USA; Weill Cornell School of Medicine, New York, NY, USA; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108183012
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2018.03.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953836PMC
May 2018

Durvalumab in Stage III Non-Small-Cell Lung Cancer.

N Engl J Med 2018 03;378(9):869-870

Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1716426DOI Listing
March 2018

Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.

Tuberc Respir Dis (Seoul) 2018 Jan;81(1):29-41

Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4046/trd.2017.0120DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771744PMC
January 2018

Patient, caregiver and physician perspectives on participating in a thoracic rapid tissue donation program.

Patient Educ Couns 2018 04 28;101(4):703-710. Epub 2017 Nov 28.

Morsani College of Medicine, Department of Oncologic Science, University of South Florida, 12901 Bruce B Downs Blvd., Tampa, FL 33612, United States; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pec.2017.11.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878993PMC
April 2018

A Bayesian pick-the-winner design in a randomized phase II clinical trial.

Oncotarget 2017 Oct 7;8(51):88376-88385. Epub 2017 Jul 7.

Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.19088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687612PMC
October 2017

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.

N Engl J Med 2017 11 8;377(20):1919-1929. Epub 2017 Sep 8.

From the H. Lee Moffitt Cancer Center and Research Institute, Tampa (S.J.A., A.C., J.E.G.), Cancer Specialists of North Florida, Jacksonville (A.V.), and Florida Hospital Cancer Institute, Orlando (T.M.) - all in Florida; Tennessee Oncology, Chattanooga, and Sarah Cannon Research Institute, Nashville - both in Tennessee (D.D.); Hospital Universitario Virgen Macarena, Seville (D.V.), and Hospital Universitario 12 de Octubre, Centro de Investigación Biomédica en Red de Cáncer, Universidad Complutense and the Spanish National Cancer Research Center (L.P.-A.), and Hospital Universitario La Paz (J.C.C.), Madrid - all in Spain; Kanagawa Cancer Center, Yokohama (S.M.), Kansai Medical University Hospital, Hirakata (T.Y.), Kurume University Hospital, Kurume (T.T.), and Nippon Medical School Hospital, Tokyo (K.K.) - all in Japan; Westmead Hospital and the University of Sydney, Sydney (R.H.), and Flinders University and Flinders Medical Centre, Bedford Park, SA (C.S.K.) - all in Australia; Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju (K.H.L.), Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju (Y.-C.K.) - all in South Korea; Vivantes Klinikum Neukölln, Berlin (M.W.); Centre Hospitalier Universitaire de Liège, Liège, Belgium (M.B.); Centre Hospitalier Universitaire Montpellier and Cancer Institute of Montpellier Val d'Aurelle, Montpellier (X.Q.), Institut Gustave Roussy, Villejuif (D.P.), and Institut de Cancérologie de l'Ouest-Site René Gauducheau, Saint Herblain (S.H.) - all in France; National Koranyi Institute of Pulmonology, Budapest, Hungary (G.O.); AstraZeneca, Alderley Park, United Kingdom (C.W.); AstraZeneca, Gaithersburg, MD (G.M., H.J., Y.H., P.A.D.); and Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey (M.Ö.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1709937DOI Listing
November 2017

Progressive hypoventilation due to mixed CD8 and CD4 lymphocytic polymyositis following tremelimumab - durvalumab treatment.

J Immunother Cancer 2017 07 18;5(1):54. Epub 2017 Jul 18.

Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-017-0258-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514517PMC
July 2017

A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment.

Neoplasia 2017 Jul 3;19(7):530-536. Epub 2017 Jun 3.

Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612; Thoracic Oncology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2017.02.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458644PMC
July 2017

Radiotherapy Rescue of a Nivolumab-Refractory Immune Response in a Patient with PD-L1-Negative Metastatic Squamous Cell Carcinoma of the Lung.

J Thorac Oncol 2017 09 10;12(9):e135-e136. Epub 2017 May 10.

Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.04.029DOI Listing
September 2017

PD-1 checkpoint blockade alone or combined PD-1 and CTLA-4 blockade as immunotherapy for lung cancer?

Expert Opin Biol Ther 2017 03 18;17(3):305-312. Epub 2017 Jan 18.

a Thoracic Oncology Department , H. Lee Moffitt Cancer Center and Research Institute , Tampa , FL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2017.1280454DOI Listing
March 2017

Strategies for power calculations in predictive biomarker studies in survival data.

Oncotarget 2016 Dec;7(49):80373-80381

Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.12124DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348326PMC
December 2016

The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer.

Expert Rev Anticancer Ther 2016 Sep 22;16(9):903-10. Epub 2016 Aug 22.

a Thoracic Oncology Department , H. Lee Moffitt Cancer Center and Research Institute , Tampa , FL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2016.1220836DOI Listing
September 2016

Moving beyond monotherapy in the immunotherapeutic arena: prospects for combination therapies in lung cancer.

Authors:
Scott J Antonia

Clin Adv Hematol Oncol 2016 Aug;14(8):616-8

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida.

View Article

Download full-text PDF

Source
August 2016

Immunotherapy: Beyond Anti-PD-1 and Anti-PD-L1 Therapies.

Am Soc Clin Oncol Educ Book 2016 ;35:e450-8

From the Department of Thoracic Oncology Moffitt Cancer Center, Tampa, FL; Respiratory Oncology Unit, University Hospital KU Leuven, Leuven, Belgium; Hospital of the University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_158712DOI Listing
January 2017

The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts.

BMC Cancer 2016 Mar 2;16:176. Epub 2016 Mar 2.

Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-016-2162-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776434PMC
March 2016

A GM-CSF and CD40L bystander vaccine is effective in a murine breast cancer model.

Breast Cancer (Dove Med Press) 2015 15;7:389-97. Epub 2015 Dec 15.

Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BCTT.S89563DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687618PMC
December 2015

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

N Engl J Med 2015 Oct 27;373(17):1627-39. Epub 2015 Sep 27.

From the Fox Chase Cancer Center, Philadelphia (H.B.); Hospital Universitario Virgen del Rocio, Seville (L.P.-A.), Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona (E.F.), and Hospital de Madrid, Norte Sanchinarro, Madrid (E.H.) - all in Spain; Vanderbilt-Ingram Cancer Center (L.H.), and Sarah Cannon Research Institute and Tennessee Oncology (D.R.S.) - both in Nashville; Thoraxklinik, Heidelberg University Hospital, Heidelberg (M.S.) and Robert-Bosch-Krankenhaus Stuttgart, Gerlingen (M.K.) - both in Germany; Duke University Medical Center, Durham, NC (N.E.R.); University of Washington, Seattle (L.Q.C.); University of Chicago Medicine and Biological Sciences, Chicago (E.E.V.); Aix Marseille University, Assistance Publique-Hôpitaux de Marseille, Marseille (F.B.), Centre Léon Bérard, Lyon (J.F.), and Centre Hospitalier Universitaire de Rennes, Rennes (H.L.) - all in France; Instituto Nacional de Cancerologia, Mexico City (O.A.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Forlì-Cesena (M.A.B.), and Ospedale di Perugia, Perugia (L.C.) - both in Italy; N.N. Blokhin Russian Cancer Research Center, Moscow (E.P.); University of Texas Southwestern Medical Center, Dallas (D.E.G.); Yale Comprehensive Cancer Center, New Haven, CT (S.N.G.); Memorial Sloan Kettering Cancer Center, New York (C.M.R., N.R.); University of Texas M.D. Anderson Cancer Center, Houston (G.R.B.); H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (S.J.A.); Bristol-Myers Squibb, Princeton, NJ (C.D., C.T.H., F.G.F.); and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (J.R.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1507643DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705936PMC
October 2015

Non-Small-Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy.

J Thorac Oncol 2015 Jul;10(7):974-84

*Ohio State University Medical Center, Columbus, Ohio; †University of California Davis Comprehensive Cancer Center, Sacramento, California; ‡H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida; §Comprehensive Cancer Center, Medical University of Vienna General Hospital, Vienna, Austria; and ‖Instituto de Biomedicina de Sevilla, Seville, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000551DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618296PMC
July 2015

Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.

J Clin Oncol 2015 Jun 20;33(18):2004-12. Epub 2015 Apr 20.

Scott N. Gettinger and Mario Sznol, Yale Cancer Center, New Haven, CT; Leora Horn, David P. Carbone, and Jeffrey A. Sosman, Vanderbilt University Medical Center; David R. Spigel, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Leena Gandhi, David M. Jackman, and F. Stephen Hodi, Dana-Farber Cancer Institute; Rebecca S. Heist and Lecia V. Sequist, Massachusetts General Hospital Cancer Center; David F. McDermott, Beth Israel Deaconess Medical Center, Boston, MA; Scott J. Antonia and Mary C. Pinder-Schenck, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Naiyer A. Rizvi, Richard D. Carvajal, and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center, New York, NY; John D. Powderly, Carolina BioOncology Institute, Huntersville, NC; David C. Smith, University of Michigan, Ann Arbor, MI; Philip Leming, Christ Hospital Cancer Center, Cincinnati, OH; Suzanne L. Topalian, Drew M. Pardoll, and Julie R. Brahmer, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; and Vindira Sankar, Christoph M. Ahlers, Mark Salvati, Jon M. Wigginton, Georgia D. Kollia, and Ashok K. Gupta, Bristol-Myers Squibb, Princeton, NJ.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/04/15/JCO.2014.58
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.58.3708
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.58.3708DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672027PMC
June 2015

Immuno-oncology combinations: a review of clinical experience and future prospects.

Clin Cancer Res 2014 Dec 23;20(24):6258-68. Epub 2014 Oct 23.

Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1457DOI Listing
December 2014

A new role for NFκB in immunosurveillance and its implications for cancer immunotherapy.

Oncoimmunology 2013 Oct 2;2(10):e25963. Epub 2013 Aug 2.

Department of Immunology; Moffitt Cancer Center; Tampa, FL USA ; Department of Thoracic Oncology; Moffitt Cancer Center; Tampa, FL USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.25963DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875605PMC
October 2013

Immunotherapy in lung cancer: "b7-bombers" and other new developments.

Semin Respir Crit Care Med 2013 Dec 20;34(6):810-21. Epub 2013 Nov 20.

Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0033-1358551DOI Listing
December 2013

Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth.

Cancer Biol Ther 2013 Sep 17;14(9):860-8. Epub 2013 Jul 17.

Department of Immunology; H. Lee Moffitt Cancer Center; Tampa, FL USA; Thoracic Oncology Department; H. Lee Moffitt Cancer Center; Tampa, FL USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.25643DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909555PMC
September 2013

Adapting to the brave new world of lung cancer treatment.

Oncology (Williston Park) 2013 May;27(5):411-2

Department of Thoracic Oncology,offitt Cancer Center and Research Institute, Tampa, Florida.

View Article

Download full-text PDF

Source
May 2013

Suspected methotrexate toxicity from omeprazole: a case review of carboxypeptidase G2 use in a methotrexate-experienced patient with methotrexate toxicity and a review of the literature.

J Pharm Pract 2012 Aug 1;25(4):477-85. Epub 2012 May 1.

Department of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0897190012442717DOI Listing
August 2012

Paclitaxel and TRAIL synergize to kill paclitaxel-resistant small cell lung cancer cells through a caspase-independent mechanism mediated through AIF.

Anticancer Res 2011 Oct;31(10):3193-204

Immunology Program, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, U.S.A.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241353PMC
October 2011

Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors.

Cancer Biol Ther 2010 Nov 15;10(10):983-93. Epub 2010 Nov 15.

Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.4161/cbt.10.10.13251
Publisher Site
http://dx.doi.org/10.4161/cbt.10.10.13251DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047092PMC
November 2010

Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody.

J Clin Oncol 2007 Mar;25(7):876-83

Abramson Family Cancer Research Institute, Abramson Cancer Center, Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.08.3311DOI Listing
March 2007

Surgical excision combined with autologous whole tumor cell vaccination is an effective therapy for murine neuroblastoma.

J Pediatr Surg 2006 Aug;41(8):1361-8

Department of Surgery, Roy J. and Lucille A Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpedsurg.2006.04.034DOI Listing
August 2006

A GM-CSF/CD40L producing cell augments anti-tumor T cell responses.

J Surg Res 2005 May 28;125(2):173-81. Epub 2005 Jan 28.

Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida, Tampa, Florida 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jss.2004.11.036DOI Listing
May 2005

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

J Clin Invest 2004 Jul;114(2):280-90

Department of Pediatrics, Institute for Molecular Medicine and Genetics, Medical College of Georgia, Augusta, Georgia 30912, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI21583DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC449750PMC
July 2004

Cell-based immune therapy for metastatic renal cancer.

Expert Rev Anticancer Ther 2003 Dec;3(6):837-49

Department of Interdisciplinary Oncology, H Lee Moffitt Cancer Center, University of South Florida, Tampa 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.3.6.837DOI Listing
December 2003

Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma.

Lab Invest 2003 Oct;83(10):1457-66

Institute of Molecular Medicine and Genetics, Augusta Veterans Affairs Medical Center, Department of Pathology, Medical College of Georgia, Augusta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.lab.0000090158.68852.d1DOI Listing
October 2003

Gene therapy for lung cancer.

Mol Biotechnol 2003 Oct;25(2):139-48

Thoracic Oncology Program, The H. Lee Moffitt Cancer Center and Research Institute. MRC3 East, Room 3056, 12902 Magnolia Drive, Tampa, FL 33612-9497, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/MB:25:2:139DOI Listing
October 2003

Gene therapy for lung cancer. An introduction.

Methods Mol Med 2003 ;75:529-43

H. Lee Moffitt Cancer Center, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/1-59259-324-0:529DOI Listing
May 2003

Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.

Int J Cancer 2002 Sep;101(2):151-5

Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.10645DOI Listing
September 2002